If your insurance “prefers” a biosimilar, here’s what that actually means and what your options are. Ellen explains the facts, it does not tell you whether to switch. That’s a decision for you and your doctor.
A biosimilar is highly similar to an original biologic, with no clinically meaningful differences in safety or effectiveness, but it is not an identical copy the way a generic small-molecule drug is. The FDA approves biosimilars through a rigorous process.
Biosimilars usually cost less, so insurers often make them the “preferred” option on the formulary. That’s a cost decision by the insurer, not a statement that your current drug is wrong for you.
You have options. If your doctor believes you should stay on your current drug, they can request an exception or appeal. Bring the insurer’s notice to your provider and decide together. Ellen can help you understand and document the appeal.
This information is for educational purposes only and does not constitute medical advice. Ellen does not recommend starting, stopping, or switching any medication. All treatment decisions should be made with your healthcare provider.